Brigit Biofarmaka Teknologi Tbk. vs Royaltama Mulia Kontraktorindo Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Royaltama Mulia Kontraktorindo Tbk. trades at Rp350 (market cap 561.31B, 8.59M 24h volume). The key difference: Royaltama Mulia Kontraktorindo Tbk. is far larger — about 3.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Royaltama Mulia Kontraktorindo Tbk. is more actively traded (8.59M versus 324K). Which is the better fit depends on your goals.
| OBAT | RMKO | |
|---|---|---|
Market Cap | 166.01B | 561.31B |
Volume | 324K | 8.59M |
Lot | 3.24K | 85.93K |
Turnover | 77.68M | 2.98B |
Average Price | 239.75 | 347.35 |
Value | 77.68M | 2.98B |
Indicative Equilibrium Price | 240 | 350 |
Indicative Equilibrium Volume | 1 | 1.41K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Royaltama Mulia Kontraktorindo Tbk was established based on Notarial Deed No. 2 datedDecember 18, 2017 of Muhammad Firmansyah, S.H., M.Kn., a public notary in Tangerang. The Company started its commercial operations in 2018.
Read more on RMKO →